Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 47 entries
Sorted by: Best Match Show Resources per page
Outcome of closed proximal phalangeal fractures of the hand.

Indian journal of orthopaedics

Singh J, Jain K, Mruthyunjaya, Ravishankar R.
PMID: 21886925
Indian J Orthop. 2011 Sep;45(5):432-8. doi: 10.4103/0019-5413.83764.

BACKGROUND: The proximal phalanx (PP) of the fingers is fractured more frequently than the middle or even distal phalanges. The problems of malunion, stiffness and sometimes loss of skin or other soft tissues associated with PP fracture increases the...

Cite
Singh J, Jain K, Mruthyunjaya, et al. Outcome of closed proximal phalangeal fractures of the hand. Indian J Orthop. 2011;45(5):432-8doi: 10.4103/0019-5413.83764.
Singh, J., Jain, K., Mruthyunjaya, & Ravishankar, R. (2011). Outcome of closed proximal phalangeal fractures of the hand. Indian journal of orthopaedics, 45(5), 432-8. https://doi.org/10.4103/0019-5413.83764
Singh, Jaswinder, et al. "Outcome of closed proximal phalangeal fractures of the hand." Indian journal of orthopaedics vol. 45,5 (2011): 432-8. doi: https://doi.org/10.4103/0019-5413.83764
Singh J, Jain K, Mruthyunjaya, Ravishankar R. Outcome of closed proximal phalangeal fractures of the hand. Indian J Orthop. 2011 Sep;45(5):432-8. doi: 10.4103/0019-5413.83764. PMID: 21886925; PMCID: PMC3162680.
Copy Download .nbib Format: NLM
Conjunctival Dehiscence and Scleral Necrosis following Iodine-125 Plaque Brachytherapy for Uveal Melanoma: A Report of 3 Cases.

Ocular oncology and pathology

Berry DE, Grewal DS, Mruthyunjaya P.
PMID: 30320099
Ocul Oncol Pathol. 2018 Sep;4(5):291-296. doi: 10.1159/000481858. Epub 2018 Feb 13.

BACKGROUND/AIMS: Plaque brachytherapy is currently the most common treatment for uveal melanoma and has many known potential complications. Here we present 3 cases of early conjunctival and scleral necrosis following iodine-125 plaque.METHODS: This study was conducted as a retrospective...

Cite
Berry DE, Grewal DS, Mruthyunjaya P. Conjunctival Dehiscence and Scleral Necrosis following Iodine-125 Plaque Brachytherapy for Uveal Melanoma: A Report of 3 Cases. Ocul Oncol Pathol. 2018;4(5):291-296doi: 10.1159/000481858.
Berry, D. E., Grewal, D. S., & Mruthyunjaya, P. (2018). Conjunctival Dehiscence and Scleral Necrosis following Iodine-125 Plaque Brachytherapy for Uveal Melanoma: A Report of 3 Cases. Ocular oncology and pathology, 4(5), 291-296. https://doi.org/10.1159/000481858
Berry, Duncan E, et al. "Conjunctival Dehiscence and Scleral Necrosis following Iodine-125 Plaque Brachytherapy for Uveal Melanoma: A Report of 3 Cases." Ocular oncology and pathology vol. 4,5 (2018): 291-296. doi: https://doi.org/10.1159/000481858
Berry DE, Grewal DS, Mruthyunjaya P. Conjunctival Dehiscence and Scleral Necrosis following Iodine-125 Plaque Brachytherapy for Uveal Melanoma: A Report of 3 Cases. Ocul Oncol Pathol. 2018 Sep;4(5):291-296. doi: 10.1159/000481858. Epub 2018 Feb 13. PMID: 30320099; PMCID: PMC6167656.
Copy Download .nbib Format: NLM
Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma.

Oncotarget

Stafman LL, Mruthyunjayappa S, Waters AM, Garner EF, Aye JM, Stewart JE, Yoon KJ, Whelan K, Mroczek-Musulman E, Beierle EA.
PMID: 29854306
Oncotarget. 2018 Apr 27;9(32):22665-22679. doi: 10.18632/oncotarget.25205. eCollection 2018 Apr 27.

Increasing incidence coupled with poor prognosis and treatments that are virtually unchanged over the past 20 years have made the need for the development of novel therapeutics for hepatoblastoma imperative. PIM kinases have been implicated as drivers of tumorigenesis...

Cite
Stafman LL, Mruthyunjayappa S, Waters AM, et al. Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma. Oncotarget. 2018;9(32):22665-22679doi: 10.18632/oncotarget.25205.
Stafman, L. L., Mruthyunjayappa, S., Waters, A. M., Garner, E. F., Aye, J. M., Stewart, J. E., Yoon, K. J., Whelan, K., Mroczek-Musulman, E., & Beierle, E. A. (2018). Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma. Oncotarget, 9(32), 22665-22679. https://doi.org/10.18632/oncotarget.25205
Stafman, Laura L, et al. "Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma." Oncotarget vol. 9,32 (2018): 22665-22679. doi: https://doi.org/10.18632/oncotarget.25205
Stafman LL, Mruthyunjayappa S, Waters AM, Garner EF, Aye JM, Stewart JE, Yoon KJ, Whelan K, Mroczek-Musulman E, Beierle EA. Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma. Oncotarget. 2018 Apr 27;9(32):22665-22679. doi: 10.18632/oncotarget.25205. eCollection 2018 Apr 27. PMID: 29854306; PMCID: PMC5978256.
Copy Download .nbib Format: NLM
Multiple genetically distinct uveal melanomas arise in the same eye of two patients with melanosis oculi.

American journal of ophthalmology

Wagley S, Belin PJ, Dollar JJ, Harbour JW, Maltry AC, Mruthyunjaya P, Schefler AC, Tang PH.
PMID: 34283976
Am J Ophthalmol. 2021 Jul 18;234:1-5. doi: 10.1016/j.ajo.2021.06.037. Epub 2021 Jul 18.

PURPOSE: To determine whether unilateral multifocal uveal melanomas (UM) in the setting of ocular melanosis (melanosis oculi) represent genetically independent tumors.DESIGN: Clinical case series.METHODS: Two patients with unilateral multifocal UM in the setting of melanosis oculi were included. Tumors...

Cite
Wagley S, Belin PJ, Dollar JJ, et al. Multiple genetically distinct uveal melanomas arise in the same eye of two patients with melanosis oculi. Am J Ophthalmol. 2021;234:1-5doi: 10.1016/j.ajo.2021.06.037.
Wagley, S., Belin, P. J., Dollar, J. J., Harbour, J. W., Maltry, A. C., Mruthyunjaya, P., Schefler, A. C., & Tang, P. H. (2021). Multiple genetically distinct uveal melanomas arise in the same eye of two patients with melanosis oculi. American journal of ophthalmology, 2341-5. https://doi.org/10.1016/j.ajo.2021.06.037
Wagley, Sushant, et al. "Multiple genetically distinct uveal melanomas arise in the same eye of two patients with melanosis oculi." American journal of ophthalmology vol. 234 (2021): 1-5. doi: https://doi.org/10.1016/j.ajo.2021.06.037
Wagley S, Belin PJ, Dollar JJ, Harbour JW, Maltry AC, Mruthyunjaya P, Schefler AC, Tang PH. Multiple genetically distinct uveal melanomas arise in the same eye of two patients with melanosis oculi. Am J Ophthalmol. 2021 Jul 18;234:1-5. doi: 10.1016/j.ajo.2021.06.037. Epub 2021 Jul 18. PMID: 34283976.
Copy Download .nbib Format: NLM
Intravitreal Pharmacotherapies for Diabetic Macular Edema: A Report by the American Academy of Ophthalmology.

Ophthalmology

Ehlers JP, Yeh S, Maguire MG, Smith JR, Mruthyunjaya P, Jain N, Kim LA, Weng CY, Flaxel CJ, Schoenberger SD, Kim SJ.
PMID: 34446301
Ophthalmology. 2021 Aug 23; doi: 10.1016/j.ophtha.2021.07.009. Epub 2021 Aug 23.

PURPOSE: To review the evidence on the safety and efficacy of current anti-vascular endothelial growth factor (VEGF) and intravitreal corticosteroid pharmacotherapies for the treatment of diabetic macular edema (DME).METHODS: Literature searches were last conducted on May 13, 2020, in...

Cite
Ehlers JP, Yeh S, Maguire MG, et al. Intravitreal Pharmacotherapies for Diabetic Macular Edema: A Report by the American Academy of Ophthalmology. Ophthalmology. 2021;doi: 10.1016/j.ophtha.2021.07.009.
Ehlers, J. P., Yeh, S., Maguire, M. G., Smith, J. R., Mruthyunjaya, P., Jain, N., Kim, L. A., Weng, C. Y., Flaxel, C. J., Schoenberger, S. D., & Kim, S. J. (2021). Intravitreal Pharmacotherapies for Diabetic Macular Edema: A Report by the American Academy of Ophthalmology. Ophthalmology, . https://doi.org/10.1016/j.ophtha.2021.07.009
Ehlers, Justis P, et al. "Intravitreal Pharmacotherapies for Diabetic Macular Edema: A Report by the American Academy of Ophthalmology." Ophthalmology vol. (2021). doi: https://doi.org/10.1016/j.ophtha.2021.07.009
Ehlers JP, Yeh S, Maguire MG, Smith JR, Mruthyunjaya P, Jain N, Kim LA, Weng CY, Flaxel CJ, Schoenberger SD, Kim SJ. Intravitreal Pharmacotherapies for Diabetic Macular Edema: A Report by the American Academy of Ophthalmology. Ophthalmology. 2021 Aug 23; doi: 10.1016/j.ophtha.2021.07.009. Epub 2021 Aug 23. PMID: 34446301.
Copy Download .nbib Format: NLM
Vitelliform Vitreoretinopathy: Clinical Implications of the Vitreomacular Interface.

Oman journal of ophthalmology

Garcia GA, Tang PH, Pan CK, Mruthyunjaya P.
PMID: 32792808
Oman J Ophthalmol. 2020 May 28;13(2):100-101. doi: 10.4103/ojo.OJO_214_2019. eCollection 2020.

Pathologies of the vitreomacular interface are implicated in a variety of sight-threatening clinical entities. The authors present a photo essay of a case of Terson syndrome with a striking premacular dehemoglobinized hemorrhage with ovoid morphology. This unique "vitelliform" finding...

Cite
Garcia GA, Tang PH, Pan CK, et al. Vitelliform Vitreoretinopathy: Clinical Implications of the Vitreomacular Interface. Oman J Ophthalmol. 2020;13(2):100-101doi: 10.4103/ojo.OJO_214_2019.
Garcia, G. A., Tang, P. H., Pan, C. K., & Mruthyunjaya, P. (2020). Vitelliform Vitreoretinopathy: Clinical Implications of the Vitreomacular Interface. Oman journal of ophthalmology, 13(2), 100-101. https://doi.org/10.4103/ojo.OJO_214_2019
Garcia, Giancarlo A, et al. "Vitelliform Vitreoretinopathy: Clinical Implications of the Vitreomacular Interface." Oman journal of ophthalmology vol. 13,2 (2020): 100-101. doi: https://doi.org/10.4103/ojo.OJO_214_2019
Garcia GA, Tang PH, Pan CK, Mruthyunjaya P. Vitelliform Vitreoretinopathy: Clinical Implications of the Vitreomacular Interface. Oman J Ophthalmol. 2020 May 28;13(2):100-101. doi: 10.4103/ojo.OJO_214_2019. eCollection 2020. PMID: 32792808; PMCID: PMC7394074.
Copy Download .nbib Format: NLM
Diagnostic and Therapeutic Challenges.

Retina (Philadelphia, Pa.)

Nagaradh K, Gokarn P, Mruthyunjaya P.
PMID: 33239544
Retina. 2021 Sep 01;41(9):1994-1998. doi: 10.1097/IAE.0000000000003041.

No abstract available.

Cite
Nagaradh K, Gokarn P, Mruthyunjaya P. Diagnostic and Therapeutic Challenges. Retina. 2021;41(9):1994-1998doi: 10.1097/IAE.0000000000003041.
Nagaradh, K., Gokarn, P., & Mruthyunjaya, P. (2021). Diagnostic and Therapeutic Challenges. Retina (Philadelphia, Pa.), 41(9), 1994-1998. https://doi.org/10.1097/IAE.0000000000003041
Nagaradh, Krishna, et al. "Diagnostic and Therapeutic Challenges." Retina (Philadelphia, Pa.) vol. 41,9 (2021): 1994-1998. doi: https://doi.org/10.1097/IAE.0000000000003041
Nagaradh K, Gokarn P, Mruthyunjaya P. Diagnostic and Therapeutic Challenges. Retina. 2021 Sep 01;41(9):1994-1998. doi: 10.1097/IAE.0000000000003041. PMID: 33239544.
Copy Download .nbib Format: NLM
Widefield imaging of retinal and choroidal tumors.

International journal of retina and vitreous

Callaway NF, Mruthyunjaya P.
PMID: 31890289
Int J Retina Vitreous. 2019 Dec 12;5:49. doi: 10.1186/s40942-019-0196-5. eCollection 2019.

BACKGROUND: Wide-field imaging plays an increasingly important role in ocular oncology clinics. The purpose of this review is to describe the commonly used wide-field imaging devices and review conditions seen in ocular oncology clinic that underwent wide-field imaging as...

Cite
Callaway NF, Mruthyunjaya P. Widefield imaging of retinal and choroidal tumors. Int J Retina Vitreous. 2019;5:49doi: 10.1186/s40942-019-0196-5.
Callaway, N. F., & Mruthyunjaya, P. (2019). Widefield imaging of retinal and choroidal tumors. International journal of retina and vitreous, 549. https://doi.org/10.1186/s40942-019-0196-5
Callaway, Natalia F, and Mruthyunjaya, Prithvi. "Widefield imaging of retinal and choroidal tumors." International journal of retina and vitreous vol. 5 (2019): 49. doi: https://doi.org/10.1186/s40942-019-0196-5
Callaway NF, Mruthyunjaya P. Widefield imaging of retinal and choroidal tumors. Int J Retina Vitreous. 2019 Dec 12;5:49. doi: 10.1186/s40942-019-0196-5. eCollection 2019. PMID: 31890289; PMCID: PMC6907111.
Copy Download .nbib Format: NLM
Practice Patterns for the Treatment of Uveal Melanoma with Iodine-125 Plaque Brachytherapy: Ocular Oncology Study Consortium Report 5.

Ocular oncology and pathology

Binder C, Mruthyunjaya P, Schefler AC, Seider MI, Crilly R, Hung A, Meltsner S, Mowery Y, Kirsch DG, Teh BS, Jennelle RLS, Studenski MT, Liu W, Lee C, Hayman JA, Kastner B, Hadsell M, Skalet AH.
PMID: 32509767
Ocul Oncol Pathol. 2020 May;6(3):210-218. doi: 10.1159/000504312. Epub 2019 Dec 11.

BACKGROUND: Treatment planning for I-125 plaque therapy for uveal melanoma has advanced significantly since the Collaborative Ocular Melanoma Study trial, with more widely available image-guided planning and improved dosimetry.OBJECTIVE: We evaluated real-world practice patterns for I-125 plaque brachytherapy in...

Cite
Binder C, Mruthyunjaya P, Schefler AC, et al. Practice Patterns for the Treatment of Uveal Melanoma with Iodine-125 Plaque Brachytherapy: Ocular Oncology Study Consortium Report 5. Ocul Oncol Pathol. 2019;6(3):210-218doi: 10.1159/000504312.
Binder, C., Mruthyunjaya, P., Schefler, A. C., Seider, M. I., Crilly, R., Hung, A., Meltsner, S., Mowery, Y., Kirsch, D. G., Teh, B. S., Jennelle, R. L. S., Studenski, M. T., Liu, W., Lee, C., Hayman, J. A., Kastner, B., Hadsell, M., & Skalet, A. H. (2020). Practice Patterns for the Treatment of Uveal Melanoma with Iodine-125 Plaque Brachytherapy: Ocular Oncology Study Consortium Report 5. Ocular oncology and pathology, 6(3), 210-218. https://doi.org/10.1159/000504312
Binder, Christina, et al. "Practice Patterns for the Treatment of Uveal Melanoma with Iodine-125 Plaque Brachytherapy: Ocular Oncology Study Consortium Report 5." Ocular oncology and pathology vol. 6,3 (2020): 210-218. doi: https://doi.org/10.1159/000504312
Binder C, Mruthyunjaya P, Schefler AC, Seider MI, Crilly R, Hung A, Meltsner S, Mowery Y, Kirsch DG, Teh BS, Jennelle RLS, Studenski MT, Liu W, Lee C, Hayman JA, Kastner B, Hadsell M, Skalet AH. Practice Patterns for the Treatment of Uveal Melanoma with Iodine-125 Plaque Brachytherapy: Ocular Oncology Study Consortium Report 5. Ocul Oncol Pathol. 2020 May;6(3):210-218. doi: 10.1159/000504312. Epub 2019 Dec 11. PMID: 32509767; PMCID: PMC7250354.
Copy Download .nbib Format: NLM
Rationale for American Society of Retina Specialists Best Practice Recommendations for Conducting Vitreoretinal Surgery during the COVID-19 Era.

Journal of vitreoretinal diseases

Chao DL, Sridhar J, Kuriyan AE, Leng T, Barnett BP, Carlin AF, Wykoff CC, Gayer S, Mruthyunjaya P, Yonekawa Y, Fawzi AA, Berrocal AM, Yeh S, Ting D, Modi Y, Zacks DN, Yannuzzi N, Afshari NA, Murray T.
PMID: 34222758
J Vitreoretin Dis. 2020 Oct 01;4(5):420-429. doi: 10.1177/2474126420941707. Epub 2020 Jul 27.

PURPOSE: To detail the rationale behind recommendations recently published by the American Society of Retina Specialists (ASRS) outlining best practices for safety of vitreoretinal surgeons and staff while performing vitreoretinal surgery during the coronavirus disease (COVID)-19 pandemic.METHODS: The committee...

Cite
Chao DL, Sridhar J, Kuriyan AE, et al. Rationale for American Society of Retina Specialists Best Practice Recommendations for Conducting Vitreoretinal Surgery during the COVID-19 Era. J Vitreoretin Dis. 2020;4(5):420-429doi: 10.1177/2474126420941707.
Chao, D. L., Sridhar, J., Kuriyan, A. E., Leng, T., Barnett, B. P., Carlin, A. F., Wykoff, C. C., Gayer, S., Mruthyunjaya, P., Yonekawa, Y., Fawzi, A. A., Berrocal, A. M., Yeh, S., Ting, D., Modi, Y., Zacks, D. N., Yannuzzi, N., Afshari, N. A., & Murray, T. (2020). Rationale for American Society of Retina Specialists Best Practice Recommendations for Conducting Vitreoretinal Surgery during the COVID-19 Era. Journal of vitreoretinal diseases, 4(5), 420-429. https://doi.org/10.1177/2474126420941707
Chao, Daniel L, et al. "Rationale for American Society of Retina Specialists Best Practice Recommendations for Conducting Vitreoretinal Surgery during the COVID-19 Era." Journal of vitreoretinal diseases vol. 4,5 (2020): 420-429. doi: https://doi.org/10.1177/2474126420941707
Chao DL, Sridhar J, Kuriyan AE, Leng T, Barnett BP, Carlin AF, Wykoff CC, Gayer S, Mruthyunjaya P, Yonekawa Y, Fawzi AA, Berrocal AM, Yeh S, Ting D, Modi Y, Zacks DN, Yannuzzi N, Afshari NA, Murray T. Rationale for American Society of Retina Specialists Best Practice Recommendations for Conducting Vitreoretinal Surgery during the COVID-19 Era. J Vitreoretin Dis. 2020 Oct 01;4(5):420-429. doi: 10.1177/2474126420941707. Epub 2020 Jul 27. PMID: 34222758; PMCID: PMC8247449.
Copy Download .nbib Format: NLM
Cyclopia with shoulder dystocia leading to an obstetric catastrophe: a case report.

Journal of medical case reports

Koregol MC, Bellad MB, Nilgar BR, Metgud MC, Durdi G.
PMID: 20507601
J Med Case Rep. 2010 May 27;4:160. doi: 10.1186/1752-1947-4-160.

INTRODUCTION: Cyclopia is a rare fetal malformation characterized by a single palpebral fissure and a proboscis associated with severe brain malformations. Approximately 1.05 in 100,000 births including stillbirths are identified as cyclopean. The prevalence is about one in 11,000...

Cite
Koregol MC, Bellad MB, Nilgar BR, et al. Cyclopia with shoulder dystocia leading to an obstetric catastrophe: a case report. J Med Case Rep. 2010;4:160doi: 10.1186/1752-1947-4-160.
Koregol, M. C., Bellad, M. B., Nilgar, B. R., Metgud, M. C., & Durdi, G. (2010). Cyclopia with shoulder dystocia leading to an obstetric catastrophe: a case report. Journal of medical case reports, 4160. https://doi.org/10.1186/1752-1947-4-160
Koregol, Mahesh C, et al. "Cyclopia with shoulder dystocia leading to an obstetric catastrophe: a case report." Journal of medical case reports vol. 4 (2010): 160. doi: https://doi.org/10.1186/1752-1947-4-160
Koregol MC, Bellad MB, Nilgar BR, Metgud MC, Durdi G. Cyclopia with shoulder dystocia leading to an obstetric catastrophe: a case report. J Med Case Rep. 2010 May 27;4:160. doi: 10.1186/1752-1947-4-160. PMID: 20507601; PMCID: PMC2886082.
Copy Download .nbib Format: NLM
Multiple genetically distinct uveal melanomas arise in the same eye of two patients with melanosis oculi.

American journal of ophthalmology

Wagley S, Belin PJ, Dollar JJ, Harbour JW, Maltry AC, Mruthyunjaya P, Schefler AC, Tang PH.
PMID: 34283976
Am J Ophthalmol. 2021 Jul 18;234:1-5. doi: 10.1016/j.ajo.2021.06.037. Epub 2021 Jul 18.

PURPOSE: To determine whether unilateral multifocal uveal melanomas (UM) in the setting of ocular melanosis (melanosis oculi) represent genetically independent tumors.DESIGN: Clinical case series.METHODS: Two patients with unilateral multifocal UM in the setting of melanosis oculi were included. Tumors...

Cite
Wagley S, Belin PJ, Dollar JJ, et al. Multiple genetically distinct uveal melanomas arise in the same eye of two patients with melanosis oculi. Am J Ophthalmol. 2021;234:1-5doi: 10.1016/j.ajo.2021.06.037.
Wagley, S., Belin, P. J., Dollar, J. J., Harbour, J. W., Maltry, A. C., Mruthyunjaya, P., Schefler, A. C., & Tang, P. H. (2021). Multiple genetically distinct uveal melanomas arise in the same eye of two patients with melanosis oculi. American journal of ophthalmology, 2341-5. https://doi.org/10.1016/j.ajo.2021.06.037
Wagley, Sushant, et al. "Multiple genetically distinct uveal melanomas arise in the same eye of two patients with melanosis oculi." American journal of ophthalmology vol. 234 (2021): 1-5. doi: https://doi.org/10.1016/j.ajo.2021.06.037
Wagley S, Belin PJ, Dollar JJ, Harbour JW, Maltry AC, Mruthyunjaya P, Schefler AC, Tang PH. Multiple genetically distinct uveal melanomas arise in the same eye of two patients with melanosis oculi. Am J Ophthalmol. 2021 Jul 18;234:1-5. doi: 10.1016/j.ajo.2021.06.037. Epub 2021 Jul 18. PMID: 34283976.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 47 entries